A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative (Q46552168)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2005

edit

Language	Label	Description	Also known as
English	A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative	scientific article published in July 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

title

A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

main subject

pegylated interferon

1 reference

based on heuristic

inferred from title

lamivudine

1 reference

based on heuristic

inferred from title

author name string

Vassiliki-Anastasia Sypsa

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

Konstantinos Mimidis

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

Nicholas C Tassopoulos

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

Dimitrios Chrysagis

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

Themistoklis Vassiliadis

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

Antonios Moulakakis

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

Maria Raptopoulou

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

Caterina Haida

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

Angelos Hatzakis

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

language of work or name

English

0 references

publication date

1 July 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

published in

Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

volume

42

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

page(s)

77-85

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

cites work

The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

21 January 2018

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with interferons (including pegylated interferons) in patients with hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics in hepatitis B virus infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of hepatitis B virus infection in vivo

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics in chronic hepatitis B patients during lamivudine therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of peginterferons

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating regression models with unknown break-points

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20738

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.20738

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

Fatcat ID

release_jleb5h4wcrdu3n7lrcwjest2v4

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/jleb5h4wcrdu3n7lrcwjest2v4

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

15962284

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15962284

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/15962284

ResearchGate publication ID

7781609

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46552168&oldid=2118047192"